Arjo AB: Low Valuation On Low Expectations
Source: SeekingAlpha
2025-06-04 06:15:00 ET
Summary
- We have built a substantial position in Arjo AB, reversing our prior bearish stance due to its attractive risk/reward profile.
- Arjo's prior growth strategy disappointed, but a management shakeup and renewed focus on efficiency and core business offer turnaround potential.
- Low expectations and valuation, robust free cash flow, and insider buying create a compelling margin of safety for investors.
- Consensus estimates are too low; even meeting expectations could drive a re-rating, with structural options and a strong balance sheet providing downside protection.
The following segment was excerpted from this fund letter.
We have built a substantial position in Swedish medtech company Arjo AB ( ARRJF ) in recent weeks. This is a first for us, as Arjo is a company we have been short on and off for the past few years. We have been critical about strategy, communication, valuation, and capital allocation....
Read the full article on Seeking Alpha
For further details see:
Arjo AB: Low Valuation On Low Expectations
Arjo AB - Class B
NASDAQ: ARRJF
ARRJF Trading
0.0% G/L:
$2.965 Last:
2,000 Volume:
$2.965 Open:
